MetLife, Inc.

New York Stock Exchange
Back to all articles
Bullish +55

MetLife stock heads into the open after a flat 0.1% gain

AI-generated analysis

📈 MetLife stock closed at USD 97.35 on September 17, 2026, edging up 0.1% with a day range between USD 96.80 and USD 98.32.

🚀 The company delivered a 25.93% year-to-date gain versus the S&P 500's 11.57%, highlighting strong relative outperformance over the current fiscal year.

💰 MetLife reported Q2 2026 earnings of USD 2.43 per share, beating consensus expectations of USD 2.30 per share.

📊 Quarterly revenue for the second quarter of 2026 was reported at approximately USD 19.07 billion.

💸 The company's board has authorized a USD 3.0 billion share buyback program for 2026 to support shareholder value.

🏦 MetLife pays a regular annual dividend of around USD 2.37 per share, providing consistent income to investors.

📅 The next scheduled earnings date is set for November 9, 2026, as per the Nasdaq-based earnings calendar.

📉 Despite its modest gain, MetLife lagged the S&P 500's 1.14% advance and the Nasdaq Composite's 1.69% climb on September 17.

🌍 Recent declines in bond yields and oil prices have created a supportive macroeconomic backdrop for financial stocks like MetLife.

Bullish Signals
  • MetLife reported Q2 2026 earnings of USD 2.43 per share, beating consensus expectations of USD 2.30 per share.
  • The company delivered a 25.93% year-to-date gain versus the S&P 500's 11.57%, demonstrating strong relative outperformance.
  • MetLife has authorized a USD 3.0 billion share buyback program for 2026 to support shareholder value.
  • The company reported quarterly revenue of around USD 19.07 billion in Q2 2026, confirming solid top-line growth.
  • MetLife offers a regular annual dividend of approximately USD 2.37 per share, providing consistent income to investors.
Full Analysis
MetLife Inc. (NYSE: MET) shares opened flat, gaining 0.1% to close at USD 97.35 on September 17, 2026, trading within its upper half of the 52-week range between USD 67.33 and USD 100.93. The stock outperformed broader benchmarks significantly over the year-to-date period, delivering a 25.93% gain compared to the S&P 500's 11.57%, while also posting a strong one-year return of 27.26% versus the index's 15.72%. Trading volume reached approximately 2.76 million shares, reflecting steady investor interest in the life insurer. Market sentiment remains anchored by the company's recent Q2 2026 financial performance, which saw earnings beat consensus expectations of USD 2.30 per share with actual results of USD 2.43 per share. Quarterly revenue was reported at around USD 19.07 billion, reinforcing positive investor confidence ahead of the next scheduled earnings release on November 9, 2026. The stock's valuation is further supported by a regular annual dividend of approximately USD 2.37 per share and a newly authorized USD 3.0 billion share buyback program for 2026. Broader macroeconomic factors continue to influence MetLife's trading environment, with recent declines in bond yields and oil prices providing a supportive backdrop for financial stocks. While the S&P 500 advanced 1.14% and the Nasdaq Composite climbed 1.69% on September 17, MetLife lagged these broader equity benchmarks despite its modest uptick. Investors are currently positioning ahead of the upcoming November earnings update, monitoring how interest rate expectations and equity market risk appetite will impact the insurer's future performance.